Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topics
- Shortages and supply disruptions (22)
- Safety monitoring and information (13)
- Manufacturing (7)
- Compliance and enforcement (6)
- Labelling and packaging (4)
- Import and export (3)
- Scheduling (national classification system) (3)
- Committees and advisory bodies (2)
- Legislation (2)
- Advertising (1)
- Clinical trials (1)
- Fees and payments (1)
- Medicinal cannabis hub (1)
Collection content
114 result(s) found, displaying 71 to 80
-
PageInformation on special considerations required for medicines for use in special populations.
-
GuidanceGuidance on the regulatory requirements for therapeutic goods that contain, or are produced from, human blood or plasma.
-
PageInformation about the shortage and the Serious Scarcity Substitution Instrument
-
Medicine shortage alertsPharmaceutical companies Novo Nordisk and Eli Lilly are discontinuing some of their insulin products.
-
Medicine shortage alertsSupply constraints will apply to Creon 25,000 unit and 35,000 unit capsules until 30 June 2026.
-
Medicine shortage alertsPharmacists can substitute whichever brand and strength of nicorandil is available during the shortage.
-
CommitteeInformation on the role and membership of ACM and proposed meeting dates.
-
FormsUpdated form used to notify us of proprietary ingredient mixtures for use in therapeutic goods.
-
User guideInformation on how to compile a literature based submission (including mixed applications).
-
FormsForms for notifying the TGA of a change in sponsorship.